|
LOC550112 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.25579990850611E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.78229997216795E-09 |
| Normal-vs-Stage2 |
6.680400E-03 |
| Normal-vs-Stage3 |
3.31640004347378E-09 |
| Normal-vs-Stage4 |
2.19799956013844E-10 |
| Stage1-vs-Stage2 |
7.776100E-02 |
| Stage1-vs-Stage3 |
2.313200E-01 |
| Stage1-vs-Stage4 |
4.558500E-03 |
| Stage2-vs-Stage3 |
1.863910E-02 |
| Stage2-vs-Stage4 |
1.516470E-03 |
| Stage3-vs-Stage4 |
1.316640E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.19859719108717E-11 |
| Normal-vs-AfricanAmerican |
2.02489999999722E-05 |
| Normal-vs-Asian |
1.245460E-04 |
| Caucasian-vs-AfricanAmerican |
3.823200E-01 |
| Caucasian-vs-Asian |
2.046000E-01 |
| AfricanAmerican-vs-Asian |
1.050820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.05279999560193E-08 |
| Normal-vs-Female |
3.32890048859724E-10 |
| Male-vs-Female |
9.315400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.2712000008186E-08 |
| Normal-vs-Age(41-60Yrs) |
3.20310000745394E-09 |
| Normal-vs-Age(61-80Yrs) |
7.77409999708212E-08 |
| Normal-vs-Age(81-100Yrs) |
3.192000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.801200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.397600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.547800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.404600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.505600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.089000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.824000E-03 |
| Classical-VS-Follicular |
4.560800E-03 |
| Classical-VS-Other |
7.543400E-01 |
| Classical-VS-Normal |
2.48530085400489E-11 |
| Tall-VS-Follicular |
1.58662999999448E-05 |
| Tall-VS-Other |
3.411600E-01 |
| Tall-VS-Normal |
9.34879951230982E-11 |
| Follicular-VS-Other |
6.213200E-01 |
| Follicular-VS-Normal |
3.496900E-03 |
| Other-VS-Normal |
6.923700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.52779999998509E-06 |
| Normal-vs-N1 |
8.68159988343109E-10 |
| N0-vs-N1 |
6.803300E-04 |
|
|
